CLINICAL_TRIALS
trial_result
· 2017-05-24
Clinical Trial Update: A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer [Phase 2]
Summary
Phase 2 trial evaluating nivolumab in participants with metastatic or unresectable bladder cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Various Advanced Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-24